Spanish-speaking women need more culturally targeted information, study finds. Latina women are almost six times more likely than white women to report great dissatisfaction and regret about their choice of breast cancer treatment, a new report says.

Those on Avastin faced 33% increased risk of dangerous side effect. The widely used cancer drug Avastin appears to be associated with a greater risk of developing blood clots in the veins of patients with a variety of cancers.

Mouse study found it was better than corn oil during gestation and lactation Women whose mothers consumed canola oil during pregnancy and breast-feeding may be less likely to develop breast cancer than those whose mothers consumed corn oil, a new study suggests.

Combined, they produce more potent anti-disease effect in postmenopausal women, study says. Scientists believe they have found out why diet and exercise affect a women's chance of breast cancer after she's past menopause, a new study says.

Black women less likely than white women to have reconstruction after mastectomy. After a mastectomy, wealthier women are more likely to have immediate breast reconstruction than their poorer counterparts, Johns Hopkins University researchers report.

Unknown mutations may account for increased odds, researchers say. The risk of breast cancer for a woman with a strong family history is four times higher than that of the general population -- even if she does not carry one of the breast cancer-linked mutations of the BRCA gene, a new study finds.

Interventions cut risk of recurrence, lengthened disease-free survival, study finds. Psychological counseling may improve the chances of survival for breast cancer patients, a new study says.

Some breast tumors produce a protein that defeats the drug. As many as 35 percent of women who take tamoxifen to prevent the return of breast cancer do not respond to the drug -- and now scientists think they know why.

But findings apply to postmenopausal women only, counters editorial Although calcium and vitamin D may keep your bones strong, these vital nutrients don't appear to help postmenopausal women lower their risk of breast cancer.

Studies are taking place at more than 1,100 facilities across the U.S. A free online service that provides clinical trial information for women diagnosed or at risk for breast cancer was launched this week by the University of California, San Francisco, Center of Excellence for Breast Cancer Care.

Lower estrogen levels among sufferers may be the reason why, researchers say. Women who experience migraines may actually have a 30 percent lower risk of developing breast cancer, say researchers from the Fred Hutchinson Cancer Research Center in Seattle.

Seven-year study of supplements found no change in disease risk Taking folic acid or other B vitamin supplements won't lower your risk of cancer, new research shows.

Exercising 30 to 60 minutes a day may offer needed protection, experts say. Obesity can wreck a person's health for many reasons. But for women, too much weight tacks on an additional danger: Studies have linked obesity and breast cancer in a variety of ways.

But benefits only apply to normal-weight women, study says. Vigorous activity can reduce the risk of breast cancer by about 30 percent in normal-weight women, according to an 11-year U.S. study of 32,269 postmenopausal women.

Receptors on the surface of breast cancer cells may be the key, scientists say.  Scientists have uncovered new clues to how breast cancer cells become resistant to the widely-used prevention and treatment drug tamoxifen.

Symptoms correlated with lower recurrence rates, study finds. Hot flashes, night sweats and joint symptoms in breast cancer patients getting endocrine treatment are signs of estrogen depletion or blockage and may point to successful treatment, British researchers report.

Method detects masses with higher blood flow speeds, likely indicating disease, study says. Radiologists can now better distinguish malignant and benign breast masses by using three-dimensional power Doppler ultrasound, a new report says.

Friday is National Mammography Day. Mammograms detect 80 percent to 90 percent of breast cancers in women without symptoms, and all women 40 and older should get a yearly mammogram, says the American Cancer Society (ACS) as it marks National Mammography Day on Friday, Oct. 17.

Besides hair loss and nausea, side effects include fatigue, vomiting, mouth sores and pain. Women starting chemotherapy for breast cancer often expect unpleasant side effects, from hair loss to nausea.

Early study suggests it pushes cells to migrate to distant sites. Nicotine may help push breast cancer cells from the original tumor to other parts of the body, contributing to the metastasis that so often kills patients.

Study suggests link to radiation therapy, but experts say treatments are safer today. Young women receiving radiation after having surgery for breast cancer are at increased risk of developing a new tumor in the opposite -- or contralateral -- breast, a new Dutch study suggests.

Only about half receive recommended tests for colon, breast, cervical disease, study finds. Screening rates for colorectal, breast and cervical cancer among older Medicaid patients are below national objectives, a new study suggests.

Large study did discover link with benign breast disease, or when tumor was larger. Drinking coffee or consuming other caffeine-laden foods does not appear to boost breast cancer risk, new research indicates.

But the benefit disappears when breast cancer drug is stopped. Tamoxifen, the drug used for more than 30 years to treat breast cancer, reduces the risk of osteoporosis-related fractures, a new study shows.

Analysis of 38 studies found painkillers showed protective effect. Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with a reduced risk for breast cancer, a new review suggests.

Study suggests the drug may make tumors easier to spot. A treatment that helps prevent one type of breast cancer in women with an evaluated risk of the disease also appears to help doctors make an earlier diagnosis of another form of breast cancer, a new study reports.

High levels of two biomarkers might indicate early tumor growth, study suggests. A simple urine test could one day be an effective way to screen for breast cancer, a new study suggests.

Detection rates rival those of two radiologist readings, study says. When it comes to reading mammogram results, two heads aren't always better than one.

Heavier, longer infants more likely to develop disease as adults, study finds. Women who are heavier and longer at birth are at increased risk of developing breast cancer later in life, British researchers report.

Patients using the technique saw episodes diminish by 68%, study finds. Breast cancer survivors who suffer from hot flashes can reduce these attacks significantly with hypnosis, a new study finds.

Findings debunk theory that DCIS recurrence varies with age. Young women diagnosed with a common form of early-stage breast cancer called ductal carcinoma in situ (DCIS) are no more likely to have recurrences than older women with the disease, a new study finds.

Patients with BRCA mutations cut their odds for malignancy when taking estrogen, study found Postmenopausal women carrying breast cancer-linked BRCA gene mutations who took hormone replacement therapy actually reduced their risk for breast cancer, researchers report.

New findings in cancer radiology also support 'seed' therapy for breast cancer, and a proton beam technique. A more intense but briefer course of radiation therapy is equally effective as the traditional longer course for certain breast cancer patients, Canadian researchers report.

Ancient therapy bested antidepressant for relieving hot flashes in study. Lifesaving treatments for breast cancer come at a cost -- many women experience hot flashes, fatigue, night sweats and more.

Even 15 years after lumpectomy, radiation, less than 5% complain of pain, survey finds. Women who had a lumpectomy and radiation to combat breast cancer have an overall quality of life several years after treatment that's on par with most adult American women, a new report says.

Researchers say trabectedin showed promise in Phase III trial, hope for FDA approval. The anti-cancer drug trabectedin shows promise in treating women with recurrent ovarian cancer, according to a study led by researchers at the University of California, Irvine.

Adjustments to diet, exercise increased telomerase levels 29%, cut 'bad' cholesterol. Major lifestyle changes can help improve levels of an enzyme called telomerase that controls cell aging, say California researchers.

A test that uses immune system biomarkers to detect lung cancer can identify the presence of the disease a year before diagnosis, long before a patient experiences any symptoms, according to researchers at the Fred Hutchinson Cancer Research Center in Seattle and the University of Michigan.

In animal studies, it eliminated aggressive growths. An experimental breast cancer vaccine eliminated tumors in laboratory animals and may someday help prevent cancer recurrence or help treat women with treatment-resistant forms of breast cancer.

Study finds getting one delays treatment, raises odds of mastectomy. Women who receive an MRI after a new diagnosis of breast cancer not only delay the start of treatment, but they are also more likely to have a mastectomy, as opposed to breast-conserving surgery.

Phase II study finds sorafenib helps reverse disease resistance to anti-hormonal therapy. The drug sorafenib may help "re-sensitize" certain breast cancer tumors to anti-hormonal drugs, Georgetown University Medical Center researchers say.

Finding among new trends in breast cancer diagnosis, treatment, experts say. While tremendous progress in screening and treatment for breast cancer has been made in recent years, some 184,000 new cases of breast cancer will be diagnosed in the United States in 2008, and about 41,000 women will die of the disease.

Researchers say finding is 'good news' for postmenopausal women taking anastrozole. Contrary to previous study results, the cancer prevention drug anastrozole does not appear to cause impairment of cognitive performance, a new study found.

Finding suggests that treatment that only aims at malignant cells might fall short. Characteristics of normal cells which are present long before any tumor appears may determine how virulent a particular cancer is going to be, new research suggests.

Zoledronic acid stabilized mineral density in premenopausal women, study finds. Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal women undergoing chemotherapy after they had surgery for early stage breast cancer, a new study found.

Drug countered effect of endocrine therapy in premenopausal patients, study finds. Zoledronic acid prevents bone loss in breast cancer patients undergoing endocrine therapy and improves bone mineral density after treatment, according to an Austrian study.

Fluorescent dyes light up diseased tissue on video monitors, helping spare healthy cells.  A new imaging system that highlights cancerous tissue makes it easier for surgeons to detect and remove tumors without harming surrounding healthy tissue, according to U.S. researchers.

Lasers heat nanotubes, then docs listen for ultrasound waves released showing tumors. Nanotechnology may offer doctors a noninvasive way to detect early stages of cancer and also help monitor treatment, a new report says.

Tibolone should not be used by those 60 and older, study says. Women 60 and older taking the hormone-replacement therapy drug tibolone to relieve menopausal symptoms are at an increased risk for stroke, a new study finds.

Obesity, previous HRT, chemo also raised chances for those on endocrine treatment, study says. Postmenopausal women with breast cancer who are receiving endocrine treatment may be at increased risk of joint issues, including arthritis, a new study finds.

Study shows recurrence after five-year mark, but numbers aren't as high as some might suspect, study says. The risk of relapse can linger for some breast cancer survivors even after completing five years of what doctors call systemic therapy, a new study found.

Finding could improve early detection of breast, thyroid and kidney diseases, researchers say, Two genes linked to breast, thyroid and kidney cancer have been identified by Cleveland Clinic researchers. The discovery of the genes SDHB and SDHD could help improve early detection of these cancers and boost patients' chances of survival.

Women worry about reactions during a time that's already difficult, study finds. Shelley Volz, now 59, got the news about her breast cancer diagnosis 10 years ago, right before she was headed from San Francisco to New York for the wedding of her younger brother.

Finding might explain why some tumors are aggressive and spread, researchers say. Scientists have identified a gene they say can promote aggressive breast cancer by acting as a kind of "crime boss," capable of changing the behavior of more than 1,000 genes within tumor cells.

 In the United States, preventive health exams account for about 1 in 12 adult outpatient visits to doctors, says a study that found that, each year between 2002 and 2004, about 63.5 million adults had a preventive health or gynecological check-up, at an annual cost of $7.8 billion.

For women who find traditional mammograms painful, new research suggests there may one day be a more comfortable alternative. Breast CT scans showed some advantages over traditional mammograms

A study in the July 29 online issue of the Journal of the National Cancer Institute finds that a traditional physician- and self-referral screening strategy held up well against the Norway approach, in which the government sends letters to all women in a specific age range inviting them to have a screening mammogram.

Calculating a woman's bone mineral density appears to shed light on her risk for breast cancer. A new study has found that high bone mineral density (BMD) predicts a greater likelihood of developing breast cancer, independent of how high her risk is on the often-used Gail model.

U.S. does better than Europe, although American whites do better than blacks, study finds. Your odds of surviving cancer depend on which country you live in. And, in the United States, it also depends on whether you're black or white, a new study finds.

Review of studies says monthly check is 'an option' for women starting in their 20s. Updated findings from an analysis of existing research continue to suggest that the oft-touted monthly breast self-exam may actually do more harm than good.

When added to risk assessment tool, SNPs made no difference, study finds. The accuracy of predicting one's chances of developing breast cancer do not seem to improve even with the recent findings of some genetic markers for the disease, a new report says.

Study finds almost 40% say docs never said condition was terminal until near death.  A new Swedish study reports that two in five widowers were never told their wives' cancer was incurable until she was near death, if they were told at all.

Study finds more than 350 common sets of genes in patients under 45. Genetic activity in breast cancer cells from younger patients could explain why tumors tend to more aggressive when they strike at a younger age.

Poor aesthetic outcome after lumpectomy linked to depression, fear, study finds. A third of women who opt for breast-conserving cancer surgery say they now have an asymmetry between their breasts that greatly affects their quality of life, a new study says.

Helps doctors make better treatment decisions. The U.S. Food and Drug Administration has approved a genetic test designed to evaluate whether a person with breast cancer is a good candidate for treatment with the drug Herceptin (trastuzumab).

Kit will help identify which patients are most likely to respond to Herceptin. A genetic test to determine whether a breast cancer patient is likely to respond to treatment with the drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug Administration.

Resveratrol, found in red wine, grape skins, inhibits abnormal cells, study finds. A compound found in red grapes and red wine suppresses abnormal cell formation that leads to most types of breast cancer, according to U.S. researchers.